Chang Gon Kim
0000-0002-4929-8501
3 papers found
Refreshing results…
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma
Peripheral blood immune cell-based biomarkers in anti-PD-1/PD-L1 therapy
Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck
Missing publications? Search for publications with a matching author name.